Google Health licenses its AI breast cancer screening tool

Medical tech company partners with Google to improve breast cancer screenings

Medical technology company iCAD Inc. announced on Monday it has signed a commercialization agreement with Google Health to utilize its artificial intelligence (AI) technology for the improvement of breast cancer screenings. In a statement, iCAD said Google will be licensing its AI tech for “breast cancer and personalized risk assessment.” This marks the first instance…

Google licenses its AI tool for breast cancer screening to a medical firm

It is the first ever commercial partnership between Google Health and the medical company iCAD.

Google to develop AI with iCAD to improve breast cancer screening

This will be Google's first commercial agreement to license its mammography AI research model to be integrated into real-world clinical practice

Google Health licenses its AI breast cancer screening tool

iCAD will have five years to bring a product to market

Google partners with med tech company to develop AI breast cancer screening tools

In a first, Google licensed its mammography AI research model to medical technology company iCAD. Together, the companies hope to improve cancer detection and risk assessment tools.

Google and a medical company will create tools with AI of detection of the cancer of the breast

Google and the medical company iCAD team up to create AI tools for breast cancer detection that could start having practical applications in just over a year